GHF Ventures connects expansion ready healthcare companies with institutional capital, clinical operators, and cross border scale. The innovation and capital arm of the Global Health Forum.
Anchored in the Global Health Forum. Activated annually at Global Health Congress.
Transformative healthcare innovation fails not because of technology, but because of misalignment. Between clinical reality and capital strategy. Between regulatory frameworks and operational execution. Between the ambition to scale and the infrastructure to do it.
GHF Ventures was built to close that gap.
A curated platform featuring companies solving real clinical and operational challenges. Founders receive structured dialogue with:
Held annually during Global Health Congress. Selected ventures present within a moderated format designed for substantive engagement, not theatrical pitching.
GHF Ventures connects founders with partners across our global network:
In partnership with WestBridge Capital, GHF Ventures connects expansion ready healthcare companies with disciplined capital, strategic guidance, and a curated network of investors and operators.
WestBridge Capital invests $10M to $500M across Series A to IPO, bringing institutional depth to every GHF Ventures engagement.
Structured engagement between clinicians, operators, and investors driving tangible outcomes.
Through strategic engagement with GHF Ventures, Sensible sharpened its commercial thesis, evolving from a single indication diagnostic model into a scalable, non invasive platform for longitudinal reproductive health monitoring.
Sensible was awarded the $25,000 Venture Forum Prize, funded by WestBridge Capital, the first prize of its kind within the GHF platform.
"The Global Health Forum was a truly transformative experience for our team. Beyond the forum, we gained invaluable guidance and a lifelong network of physicians, leaders, and investors who genuinely want to help us make an impact."
Nandini Kanthi
CEO & Co Founder, Sensible
Founder engagement within Global Health Forum created direct access to senior leaders, resulting in strategic conversations with IBM and Elsevier and tangible funding and engagement outcomes.
"What made the Global Health Forum exceptional was the openness of the environment and the ability to engage directly with senior leaders… In a very real sense, the Forum played a concrete role in moving our work forward."
Mireille van Hal
Co Founder, Keendoc
Selected ventures may receive strategic advisory support and non dilutive capital aligned with governance first principles. (No funding amounts disclosed.)
GHF Ventures aligns directly with the broader pillars of Global Health Congress 2026.
"The intersection of clinical intelligence and institutional capital."
GHF Ventures is designed for expansion ready companies that demonstrate:
Engagement is selective and aligned with long term partnership.
Engagement is selective and aligned with long term partnership.
2026
Takes place on October 11.
Selected ventures engage with institutional investors, health system leaders, and cross border partners in a curated environment designed for disciplined capital alignment.
GHF Ventures operates within the broader Global Health Forum ecosystem.
A curated capital and governance alignment platform within the Global Health Forum.
No. It is not a cohort based accelerator. It is a selective capital alignment ecosystem that also operates focused accelerator programs addressing specific gaps in healthcare.
There is no standard equity model. Engagement is relationship driven and structured case by case.
Companies with measurable traction or validated pilots.
No. GHF Ventures supports international collaboration, including U.S. India corridor engagement.
No. Capital alignment occurs through structured engagement with investors.
Access is selective. Begin the conversation.
We review all submissions personally. You will hear from us within 5 business days.
Prefer to reach out directly?